In today’s recent session, 8.51 million shares of the Hookipa Pharma Inc (NASDAQ:HOOK) have been traded, and its beta is 0.98. Most recently the company’s share price was $0.77, and it changed around $0.01 or 0.65% from the last close, which brings the market valuation of the company to $76.19M. HOOK at last check was trading at a discount to its 52-week high of $2.05, offering almost -166.23% off that amount. The share price’s 52-week low was $0.41, which indicates that the recent value has risen by an impressive 46.75% since then. We note from Hookipa Pharma Inc’s average daily trading volume that its 3-month average coming to 551.43K.
Hookipa Pharma Inc (NASDAQ:HOOK) trade information
Instantly HOOK has been showing a green trend so far today with a performance of 0.65% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -4.94% year-to-date, but still up 0.98% over the last five days. On the other hand, Hookipa Pharma Inc (NASDAQ:HOOK) is 9.59% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 74.33% from its current value. Analyst projections state that HOOK is forecast to be at a low of $3 and a high of $3.
Hookipa Pharma Inc (HOOK) estimates and forecasts
Hookipa Pharma Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 69.42 percent over the past six months and at a 32.00% annual growth rate that is well above the industry average of 12.90%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 63.00% in revenue this quarter, and will report an increase of 77.30% in the next quarter. The year-over-year growth rate is expected to be 63.40%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of $2.8 million in revenue for the current quarter. 3 analysts expect Hookipa Pharma Inc to make $10.47 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $4.39 million and $2.68 million respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -36.20%. Forecasts for the next quarter put sales growth at 290.80%.
Hookipa Pharma Inc earnings are expected to increase by 58.43% in 2024, but the outlook is positive 14.50% per year for the next five years.
